OrbiMed Genesis Fund, L.P.
OrbiMed Genesis Fund, L.P. is a hedge fund based in New York, New York. According to its most recent Form D, filed Dec 5, 2025, the fund has sold $353,340,923 of interests to 107 investors since its first sale in Nov 2019. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Carl Gordon; OrbiMed Advisors LLC; Geoffrey Hsu.
Performance
No verified returns have been reported for this fund. As a rough guide, Orbimed Advisors LLC, which manages it, disclosed U.S. stock holdings that returned an estimated +16.0% 2026 YTD through Jun 30 (S&P 500: +9.5%), based only on its public 13F filings. Over a longer period, Q3 2024 to Q2 2026, the estimate is +48.4% (S&P 500: +37.2%).
This estimate covers the firm's whole disclosed long U.S. stock portfolio. It is not this fund's return and excludes dividends, fees, shorts, derivatives, bonds, cash and trading within each quarter.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $353,340,923Cumulative sales reported on Form D
- Investors
- 107
- First sale
- Nov 7, 2019
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Carl Gordon; OrbiMed Advisors LLC; Geoffrey Hsu
- Latest Form D
- Dec 5, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about OrbiMed Genesis Fund, L.P.
What is the minimum investment for OrbiMed Genesis Fund, L.P.?
OrbiMed Genesis Fund, L.P.'s latest Form D, filed Dec 5, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in OrbiMed Genesis Fund, L.P.?
OrbiMed Genesis Fund, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has OrbiMed Genesis Fund, L.P. raised?
OrbiMed Genesis Fund, L.P. reports $353,340,923 sold from 107 investors on its Form D filed Dec 5, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is OrbiMed Genesis Fund, L.P. based?
OrbiMed Genesis Fund, L.P. is based in New York, New York and is managed by Orbimed Advisors LLC.
When did OrbiMed Genesis Fund, L.P. launch?
OrbiMed Genesis Fund, L.P. reports its first sale in Nov 2019.
Size compared with every hedge fund
Raised more than 75% of the 2,544 hedge funds based in New York, and more than 78% of all 10,308 that report sales.